Novartis Investigative Site

Bologna, Emilia-Romagna 40139

0 studies enrolling now · 6 studies all time

What they study most

Breast Neoplasms, Cancer, Metastases, Brain, Ovarian Cancer, Purpura, Thrombocytopaenic, Idiopathic, Renal Cell Carcinoma (RCC), Thrombocytopaenia

Studies at this site

• Study Comparing Lapatinib (GW572016) And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer — Completed
• Efficacy and Safety of Pazopanib Monotherapy After First Line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — Completed
• A Study to Evaluate Pazopanib as an Adjuvant Treatment for Localized Renal Cell Carcinoma (RCC) — Completed
• Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer — Completed
• A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia — Completed
• EXTEND (Eltrombopag Extended Dosing Study) — Completed